Phase I/II Study of Sonoporation and Chemotherapy in Patients with Pancreatic Cancer
Summary
The purpose of this phase I/II study is to evaluate the safety and efficacy of sonoporation in addition to standard of care chemotherapies( gemcitabine, nab-paclitaxel, FOLFIRINOX) in patients with pancreatic cancer.
General Information
NCT#: NCT04821284
Study ID: 20F.1207
Trial Phase: Phase I/II
Trial Sponsor: Thomas Jefferson University
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Leucovorin, FOLFIRINOX, Sonoporation